MED-EL
1
10M
1
0.03
1
- Areas of investment
Summary
In 1989 was created MED-EL, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Innsbruck. The fund was located in Europe if to be more exact in Austria.
For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Emergency Medicine, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight AudioCure Pharma.
The current fund was established by Erwin Hochmair, Ingeborg Hochmair.
The top activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
The typical case for the fund is to invest in rounds with 2 participants. Despite the MED-EL, startups are often financed by Ju00fcrgen Schumacher, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.03
- Investments by industry
- Biotechnology (1)
- Therapeutics (1)
- Education (1)
- Emergency Medicine (1)
- Investments by region
-
- Germany (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AudioCure Pharma | 29 Nov 2016 | Biotechnology, Education, Therapeutics, Emergency Medicine | Early Stage Venture | 10M | Berlin, Berlin, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.